Homepage

CBD-infused gum

AXIM Biotechnologies has developed the first rapid (10-minute) point-of-care test that measures the concentration of neutralizing antibodies to COVID-19.

CLINICAL THERAPEUTICS

AXIM’s clinical therapeutic research focuses around an enzyme called “QSOX1” where the company hopes to bring a novel oncology drug to market 

nausea

AXIM is in development of various “point-of-care” diagnostic testing products designed for the early detection of cancer

covid 19 Testing

AXIM is in development of various “point-of-care” diagnostic testing products designed for the early detection of cancer

the Latest On Our Research

Founded in 2014, AXIM® Biotechnologies, Inc. (AXIM) is a vertically integrated research and development company focused on changing diagnosis and treatment for oncology and SARS-CoV-2 (COVID-19). AXIM’s NeuCovix is the first rapid diagnostic test measuring levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells. Additionally, the Company is developing rapid diagnostic tests for the early detection of cancer and proprietary small molecules drugs to treat cancer and block metastasis.

Tauri-Gum Product Line Now Available at Select Mobil and Shell Gas Station Convenience Store Locations
NEW YORK, NY, Oct. 21, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the[...]
The United States Defense Logistics Agency Officially Lists Tauriga Sciences, Inc. as an Authorized Vendor
NEW YORK, NY, Oct. 15, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the[...]
Tauriga Sciences, Inc. Updates and Standardizes the Packaging of its Tauri-Gum Blister Pack
The Blister Pack Design has been Updated for All 6 Tauri-Gum™ Flavors and Now Includes Halal Certification Icon, QR Code,[...]
Tauriga Sciences Inc. Retains FAMR to Commence Bidding Process on Several Identified U.S. Government Contracts
NEW YORK, NY, Oct. 09, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue[...]
Tauriga Sciences, Inc. Enters into Strategic Alliance with Think BIG, LLC, Social Impact Startup Founded by CJ Wallace, Son of Christopher “The Notorious B.I.G.” Wallace.
NEW YORK, NY & LOS ANGELES, CA, Oct. 07, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or[...]
Tauriga Sciences Inc. Officially Approved to Operate as a U.S. Government Vendor
The Company is Now Legally Authorized to Bid on Government Contracts New York, NY, Oct. 06, 2020 (GLOBE NEWSWIRE) --[...]